Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

More Prosecutors Join Herbal Supplement Inquiry

By Drug Discovery Trends Editor | March 11, 2015

Prosecutors from Connecticut, Indiana and Puerto Rico have joined New York’s attorney general in an investigation of the herbal supplement industry, saying they’re building on the long track record of state attorneys general upholding the rights of consumers.
 
“New Yorkers and consumers nationwide deserve confidence that when an herbal supplement is represented as authentic, pure and natural, it really is,” New York Attorney General Eric Schneiderman said.
 
The coalition’s formation follows allegations by Schneiderman that DNA tests on certain store-brand supplements found contaminants but none of the herbs listed on the label. Schneiderman ordered the products off the shelves last month and requested detailed quality control information from four manufacturers.
 
Schneiderman’s office didn’t specify what action the coalition would take.
 
Supplement-makers aren’t required to disclose to the U.S. Food and Drug Administration or consumers the information they have about the safety or purported benefits of their products. The federal agency takes action only after a supplement is proven unsafe.
 
Schneiderman said lax oversight of supplements can have serious public health consequences, noting hundreds of deaths linked to herbal weight-loss supplements containing the stimulant ephedra before the FDA banned sale of the herb in 2004.
 
“The significant issues recently raised about herbal supplements are a concern that must be taken seriously so as not to further jeopardize the health and safety of people ingesting these products,” Indiana Attorney General Greg Zoeller said in a statement.
 
Last month, Schneiderman said DNA barcoding tests commissioned by his office on six popular herbal supplements found that of hundreds of bottles tested, 4 out of 5 contained none of the herbs listed on the labels. The supplements included ginseng, echinacea, St. John’s wort and ginkgo biloba.
 
Consumer protection groups focused on exposing fraud in the supplement industry criticized Schneiderman’s use of DNA tests without additional chemical analysis, saying many products that use extracts of a plant’s active ingredients would not test positive for DNA but could still be effective. The industry leveled the same criticism.
 
“The NY Attorney General’s office continues to ignore the scientific facts of his investigation, as well as the fact that herbal botanical supplements are already properly regulated by the Food and Drug Administration,” Steve Mister, president of the supplement trade group Council for Responsible Nutrition, said via email. “It’s ironic that he continues to call for transparency, when his office refuses to release its test results and methodology, which scientists familiar with botanicals and DNA testing say is inaccurate.”

Filed Under: Drug Discovery

 

Related Articles Read More >

Sai Life Sciences exec: GLP-1 boom has ‘exploded the peptide field’ as firm opens new center
Novartis in the Pharma 50
Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE